BPC 157 for Erectile Dysfunction: What the Evidence Actually Shows BPC 157 erectile dysfunction study: what the current evidence actually shows BPC 157 was discovered over 30 years ago. Its patent was licensed to multiple pharmaceutical companies over time, but none identified meaningful commercial potential. A Phase 1 human trial (NCT02637284), registered in 2015, BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & BPC 157 Erectile Dysfunction Study: What the Current Evidence Shows BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts